Farahnak Assadi to Hypertension
This is a "connection" page, showing publications Farahnak Assadi has written about Hypertension.
Connection Strength
3.461
-
Long-term cardiometabolic consequences among adolescent offspring born to women with type1 diabetes. Prim Care Diabetes. 2022 02; 16(1):122-126.
Score: 0.700
-
Allopurinol enhances the blood pressure lowering effect of enalapril in children with hyperuricemic essential hypertension. J Nephrol. 2014 Feb; 27(1):51-6.
Score: 0.403
-
The growing epidemic of hypertension among children and adolescents: a challenging road ahead. Pediatr Cardiol. 2012 Oct; 33(7):1013-20.
Score: 0.361
-
Diagnosis of hypokalemia: a problem-solving approach to clinical cases. Iran J Kidney Dis. 2008 Jul; 2(3):115-22.
Score: 0.276
-
Vasoconstrictor-induced hypertension following multiple blood transfusions in children with congenital hemolytic anemia. Iran J Kidney Dis. 2008 Jul; 2(3):132-6.
Score: 0.276
-
Relation of left ventricular hypertrophy to microalbuminuria and C-reactive protein in children and adolescents with essential hypertension. Pediatr Cardiol. 2008 May; 29(3):580-4.
Score: 0.265
-
C-reactive protein and incident left ventricular hypertrophy in essential hypertension. Pediatr Cardiol. 2007 Jul-Aug; 28(4):280-5.
Score: 0.257
-
Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension. Pediatr Cardiol. 2007 Jan-Feb; 28(1):27-33.
Score: 0.251
-
Autonomic dysreflexia manifested by severe hypertension. Med Sci Monit. 2004 Dec; 10(12):CS77-9.
Score: 0.215
-
Validity of anthropometric indices in predicting high blood pressure risk factors in Iranian children and adolescents: CASPIAN-V study. J Clin Hypertens (Greenwich). 2020 06; 22(6):1009-1017.
Score: 0.158
-
Performance of modified blood pressure-to-height ratio for diagnosis of hypertension in children: The CASPIAN-V study. J Clin Hypertens (Greenwich). 2020 05; 22(5):867-875.
Score: 0.156
-
The Growing Epidemic of Chronic Kidney Disease: Preventive Strategies to Delay the Risk for Progression to ESRD. Adv Exp Med Biol. 2019; 1121:57-59.
Score: 0.143